Please login to the form below

Not currently logged in
Email:
Password:

Chase Pharmaceuticals appoints former Allergan president

Douglas Ingram joins as chief executive officer
Douglas Ingram

Washington-based Chase Pharmaceuticals has appointed Douglas Ingram as its new chief executive officer to replace John Siebert, who will continue working with the company in an advisory capacity.

He brings to the role nearly 20 years of experience in biotech, pharmaceutical and medical devices leadership.

Prior to serving as president of Allergan, Ingram directed the company's operations in Europe, the Middle East and Africa and was responsible for various aspects of its global organisation including regulatory affairs and external communications.

Ingram said: “I am privileged to lead Chase Pharmaceuticals as we execute an elegant approach to the development of new Alzheimer's treatments.

“Our goal is to build a strong CNS biopharmaceutical company to improve the lives of the millions of patients and their families burdened by this devastating disease. We have an important mission and I am excited to play a leadership role in this journey.”

As CEO, Ingram will focus on the direction of Chase Pharmaceuticals' development and commercialisation of improved treatments for neurodegenerative disorders, in particular its current work on symptomatic treatment of Alzheimer's disease.

Greg Parekh, chairman of Chase Pharmaceuticals, said: “Doug has a proven track record of disruptive approaches, building strong teams and delivering above-market performance … I am confident that Doug will successfully develop Chase to its fullest potential.”

15th December 2015

From: Healthcare

Share

Tags

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Hamell

Hamell is a full-service agency with a clear focus on delivering evidence-based, sustained behaviour change. So, whether you are looking...

Latest intelligence

PME Jan cover
AstraZeneca’s focus on diagnosing and managing chronic kidney disease
People living with chronic kidney disease are in urgent need of new and improved approaches to diagnosis and care...
Delphi Technique Virtual Co-creation: A Customer Story
How a client leveraged the Delphi technique to co-create a consensus statement and algorithm using virtual touchpoints....
AI healthcare
Three ways AI will change healthcare in the next decade
Looking forward, there is no doubt that AI will continue to take centre stage in global healthcare initiatives...

Infographics